Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01491646 · ClinicalTrials.gov registry record

Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension

A clinical trial, sponsored by National Jewish Health.

Completed
Registry status
25
Enrollment target

NCT01491646 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01491646 has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
25 participants
Enrollment target

Study Summary

Pulmonary hypertension (PH) is a condition in which high blood pressure develops in the lungs and right side of the heart. People with PH suffer from shortness of breath, chest pain, heart failure, heart rhythm problems, and fainting. PH is diagnosed using a test called a cardiac catheterization where blood pressure is measured directly using a tube placed in the right side of the heart and lung arteries. Because a cardiac catheterization is invasive, researchers are investigating ways to diagnose PH using imaging tests that are not invasive. The study will evaluate whether or not a magnetic resonance image (MRI) of the heart, and blood tests can detect PH.

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2010-11
Est. Completion 2013-10

Sponsor

National Jewish Health

83 total trials

What the Registry Record Tells You About NCT01491646

The ClinicalTrials.gov registry entry for NCT01491646 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01491646 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01491646 about?

NCT01491646 is a clinical study titled "Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension". Pulmonary hypertension (PH) is a condition in which high blood pressure develops in the lungs and right side of the heart. People with PH suffer from shortness of breath, chest pain, heart failure, heart rhythm problems, and fainting. PH is diagnosed using a test called a cardiac catheterization whe...

What is the current status of trial NCT01491646?

This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-11. Estimated completion is 2013-10.

Who is sponsoring clinical trial NCT01491646?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.